Abstract
Background/Aim: Breast cancer treatment represents a substantial amount of health-care costs and has a negative impact on womens' psychological health. Day-Surgery managment (DS) is a favorable alternative to a classic inpatient setting. In our prospective study we evaluated DS-treatment feasibility in terms of patient satisfaction, same-day-discharge rate, surgical-reintervention rate, psychological impact and costs. Patients and Methods: We operated on 131 early breast cancer patients in DS. Surgical outcomes were evaluated. In 64 DS-treated breast cancer patients, psychological outcomes were analyzed using validated psychometric questionnaires and comparison was made with a corresponding group of women treated as inpatients. Results: The same-day-discharge rate was 95.4%. No patient required readmission. The surgical-reintervention rate was 6.2%. DS-treatment significantly reduced anxiety (p=0.05) and depression (p=0.01) and afforded cost savings of 49%. Conclusion: DS-treatment of early breast cancer was feasible, with low reintervention rate, reduced anxiety and depression, high patients' satisfaction and substantial financial savings.
Treatment for breast cancer, which is the most common female malignancy in developed countries, accounts for a substantial amount of national healthcare costs. In various countries, a heavy burden is imposed upon the health care system due to the increase in medical care costs (1), which are, in part, due to the introduction of highly advanced expensive drugs and costly medical technologies. However, innovations such as the sentinel lymph node biopsy (SLNB), in association with breast-conserving surgery in early breast cancers, have substantially reduced the impact of surgical treatment, in terms of post-operative pain, need for surgical drains and patient autonomy. In conclusion, a considerable proportion of breast cancer patients may undergo quadrantectomy with SLNB and be safely discharged from the hospital on the very same day. In spite of this, in our country most patients undergoing breast conserving surgery and SLNB for treatment of early breast cancer are hospitalized for at least one or two nights. Considering that in most countries reimbursements are calculated on a fee-for-service basis, according to the diagnosis-related-group (DRG) system guidelines, it is clear that treatment for early breast cancer in a Day Surgery setting (DS) could represent a significant saving as it relates to cost of care (2).
Another relevant aspect of diagnosis and treatment for breast cancer is its dramatic negative psychological impact upon women, secondary to the fear of either dying of disease and/or impaired body image (3-5). The need for semi-private accommodations with other critical oncologic patients may further worsen psychological responses. We hypothesize that a short hospital stay for a surgical procedure with same-day discharge versus the standard two-three days inpatient hospitalization, may reduce anxiety and the depressive mood associated with diagnosis and treatment. Studies have been done to evaluate the feasibility of same-day discharge after breast cancer surgical treatment, none of which evaluated the psychological outcome of such an approach, by means of validated psychometric instruments (6).
In this prospective study, the feasibility of same-day discharge after early breast cancer surgical treatment was tested in terms of patients' satisfaction with the procedure, need for overnight stay and reoperation. A cost-benefit analysis was performed in order to compare DS treatment with standard inpatients' surgical management in terms of health care system costs. Furthermore, patients' outcomes were studied in terms of mood, anxiety and quality of life, by means of validated psychological testing, and compared with a control group of patients undergoing standard inpatient surgical treatment.
Patients and Methods
Patients selection. In this prospective study, we identified 131 patients with early breast cancer undergoing surgery at our Breast Unit of the Gynaecology and Obstetrics Department, Careggi Hospital, University of Florence and satisfying inclusion criteria for treatment in a DS setting. DS was defined as a surgical operation allowing patients to go home later on the very same day. Inclusion criteria were: preoperative histological diagnosis of in situ or invasive breast carcinoma with a diameter of <3 cm, favorable proportion between tumor and breast size allowing for breast conserving surgery, fairly good clinical conditions and low risk of lymph node metastases, meaning that both clinical examination and axillary ultrasound resulted negative. Ultrasonographic criteria for axillary lymph node evaluation are given in detail elsewhere (7-9). Patients operated in DS did not receive frozen section examination of the sentinel node. All patients gave their written informed consent. Protocol was approved by the local Ethics Committee.
Surgical procedure. The breast surgical DS procedure consisted of a wide local excision or a quadrantectomy with clear margins of at least 1 cm from the tumor, associated with SLNB. It was done under local anesthesia, using a mixture of Lidocaine hydrochloride 2% and Ropivacaine hydrochloride 10 mg/ml. Sedation was administered (Propofol 10 mg/ml I.V.) with mask ventilation. No surgical drain was left in situ. Ice packing was applied postoperatively during the first hour. All removed nodes were submitted for standard histological testing. In cases where sentinel lymph node macrometastases were detected at final histology, patients were readmitted mostly to undergo axillary lymph node dissection (ALND), which by contrast was not performed in cases where micrometastases or isolated tumor cells (ITC) were identified.
Questionnaries administration. We administered questionnaires to a subgroup of 64 patients with invasive breast carcinoma treated with breast-conserving surgery and SLNB, in order to rate their degree of satisfaction with the procedure and post-operative pain. The Visual Analogue Scale (VAS) (10) was used to assess pain 1 day and 7 days after the procedure. To explore the psychological impact of the procedure, in terms of mood, anxiety and depression, we administered specifically designed, validated questionnaires, one week before surgery and one month after surgery. Mood was evaluated with the 5 items “Satisfaction with Life Scale (SWLS)” (11), anxiety with the 20 items “State-Trait Anxiety Inventory” (STAI) (12) and depression with the 20 items “Center for Epidemiologic Studies Depression Scale” (CES-D) (13). We then identified a control group consisting of 64 patients matched for age, tumor stage and clinical conditions, who underwent breast-conserving surgery and SLNB under general anesthesia, with traditional inpatient hospitalization for at least one post-operative night. The same questionnaries were administrated to the control group, with the same timing.
End points. End points of our study were: same-day discharge rate (defined as the percentage of patients operated on and returning home the same day of the surgical procedure), early readmission (defined as need for readmission within 48 hours from the surgical procedure) and reintervention rate (defined as the percentage of patients who needed a second surgical intervention for various reasons, i.e. axillary clearance, inadequate surgical margins, complications).
Cost assessment. By conferring with the Business Office of the hospital, the incurred costs were compiled for each DS procedure and for each traditional inpatient procedure.
Compliance with ethical standards. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Statistical analysis. Patient characteristics were analyzed using Fisher's exact test or the Chi-square test, as appropriate. Results of the psychometric questionnaires were submitted for analysis of variance using the ANOVA test (IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.) A p-value <0.05 was considered statistically significant.
Results
DS feasibility. We analysed 131 patients with a mean age of 62 years. Preoperative diagnosis was in situ carcinoma in 37 cases (28%) and invasive carcinoma in 94 cases (72%). Overall, a wide local excision was performed in 112 (85.5%) patients and a quadrantectomy in 19 (14.5%) patients. In 81 of 94 women (86%) with invasive carcinoma a SLNB was concurrently performed. Advanced age and/or relatively poor clinical conditions, were reasons for renouncing to SLNB in the remaining 13 patients. Same-day discharge was feasible in 125 of 131 patients (95.4%). There were no patients requiring early readmission for complications. Among the remaining 6 patients, 3 were hospitalized because the operation was performed in the afternoon, although it was scheduled for the morning hours. In 5 cases, the pathological examination revealed an upgrade to invasive carcinoma initially diagnosed as ductal carcinoma in situ (DCIS), therefore we had 99 cases of invasive breast cancer (75.6%) and 32 cases of carcinoma in situ (24.4%). Pathological features are reported in Table I. Among the 9 positive SLN cases (macrometastases), 5 underwent subsequent ALND, 4 either refused or had comorbidities discouraging a second surgical intervention. Overall, among the 81 patients submitted for SLNB, 76 (93.8%) did not receive any additional surgery, while 5 patients (6.2%) underwent a second surgical procedure to perform ALND. In 2 cases (2.4%) a widening of the breast resection margins was concurrently performed.
Questionnaries results. Between July 2016 and July 2018, we operated on 67 women with invasive breast carcinoma using breast conserving surgery and SLNB in DS setting. They were all invited to rate their degree of satisfaction with the procedure and to assess their emotional burden by answering questionnaires. Two of them declined; one patient was excluded because of language barrier. The remaining 64 patients were able to be evaluated for satisfaction, pain and psychological aspects. Clinical and pathological characteristics of these patients and those of the corresponding control group are presented in Table II. Data concerning pain are reported in Figure 1. According to the psychometric tests, we found a statistically significant reduction in depression and anxiety scores following DS (p=0.01 and p=0.05, respectively) compared to women treated in a traditional inpatient setting (Figure 2).
Pathological features of the 131 patients with breast carcinoma operated on in DS setting.
Economic analysis. Costs associated with breast cancer DS treatment and with traditional inpatient setting were evaluated. Average cost for each DS patient was €469, compared to €999 for each one-night-inpatient case, reflecting savings of €530. The amount saved during the study period (125 × €530=€66250) adjusted for costs related to needed reintervention (5 × €999=€4995), was €61255, corresponding to a 49% savings for treatment in DS.
Discussion
We found that surgical management of early breast cancer in DS was feasible and well accepted by most patients. Our results concerning patient satisfaction were similar to those reported by Friedman (14) and by Goodman (15) whereas they differed from those of Marchal who reported a higher refusal rate (13.9%) (16). In the current study, more than 95% of patients were discharged on the same day of surgery, as planned. Actually, only 3 patients (2.3%) were not discharged for clinical reasons, while in another 3 cases, patients remained in the hospital because the surgical procedure was delayed to the afternoon hours. A different timing of these 3 operations could have therefore raised the same-day discharge rate to 97.7%. Overrunning theatre lists as a cause of overnight admission have been reported also by others (17). Nevertheless, our finding is in line with other studies on DS management of breast cancer which reported same-day discharge rates ranging from 86% to 100% (14-26). However, there is one small randomized study reporting lower rate of discharge on the same day of surgery (47%) mainly due to axillary clearance following frozen section evaluation of the sentinel nodes (27). In the current series, there were no patients requiring early post-operative readmission, as also reported by others (14-17, 20, 23), whereas some studies reported readmission rates of 6-7% due to post-op complications (19, 25). Pain scores did not differ between patients operated under local anesthesia with sedation in DS and those operated on traditionally, using general anesthesia. More than 96% of patients reported positive feedback about their experience in DS. Two patients (3.1%) were not satisfied because of excessive familial burden and anxiety related with staying at home without medical supervision during the first night. This is in line with the majority of previous reports on the topic (14, 19, 20, 23, 24), with the exception of the study by Margolese, in which 40% of patients would have preferred to have spent at least one night in the hospital (28). It should be noted that a direct comparison with this latter study is not feasible as patients submitted for major breast surgery procedures such as mastectomy and ALND, were also included. Our decision of renouncing by principle to the frozen section examination of the sentinel nodes might be questioned since it is associated with a high risk of reintervention. However, the reintervention rate in the current series was only 6.2%, supporting our belief that with careful pre-operative evaluation of the axillary lymph nodes by ultrasound and considering further criteria of risk for axillary node metastases (7, 9), it is possible to select breast cancer patients with a reasonably low risk of lymph node metastases, that may safely benefit from this minimally invasive surgical approach. Indeed, previous studies on the same subject not using axillary ultrasound in the preoperative assessment, reported much higher reintervention rates, ranging from 28-40% (19, 22). After the publication of the ACOSOG Z0011 (29) and IBCSG 23-01 trials (30) and the diffusion of the American Society of Clinical Oncology clinical practice guideline updated in 2016 (31), pointing out the futility of lymphadenectomy even in the presence of metastases in the sentinel lymph node, the traditional concept of ALND in breast cancer is currently questioned (32). The utility of preoperative axillary ultrasound, as well as the possibility of avoiding ALND, are currently being evaluated in an ongoing prospective study promoted by Gentilini and Veronesi (33).
Clinical and pathological characteristics of the patients with invasive breast cancer treated in Day surgery (DS) and in a traditional inpatient setting (controls) and submitted for psychological testing.
Pain score according to the visual analogue scale (VAS) 1 (1a) and 7 days (1b) after the surgical procedure in patients operated in Day Surgery (DS) and in a traditional inpatient setting (controls).
Baseline and post-operative mean scores of anxiety (2a; 2c), according to “State-Trait Anxiety Inventory” (STAI)(12), and depression (2b; 2d), according to the Center for Epidemiologic Studies Depression Scale (CES-D scale) (13), in women treated for breast cancer in day surgery (DS) and in a traditional inpatient setting (controls).
One of the most important outcomes of our study was related to psychological issues. Using validated quality-of-life-assessment tools, we obtained statistically significant lower anxiety (p=0.05) and depression scores (p=0.01) in patients who underwent a DS procedure in comparison with patients having an overnight stay. Indeed, patients with breast cancer have often a high grade of anxiety and depression connected with their diagnosis and surgery (3-5). Our findings support the hypothesis that early recovery in the familial environment may contribute to decreased anxiety, prevent the development of depression and feeling of helplessness related to illness. It is also possible that avoiding prolonged contact with other suffering oncologic patients may aid in reducing patients' anxiety and in preserving their positive self-image. To our knowledge, this is the first study to investigate the influence of early breast cancer treatment in a DS setting on patients' anxiety and depression using validated questionnaires.
The last relevant finding of our study was the economic outcome. Early breast cancer treatment in a DS setting was associated with savings of 49%. Obviously, the cost of the operation was similar in outpatient and inpatient groups, but the further 1-2 days of hospitalization as inpatients, added an average cost of €530 per day. In the current series, even after adjusting for costs due to reintervention, breast cancer treatment in DS resulted in a potential savings of over €60,000. Our results are in line with five previous studies evaluating the economic outcomes of breast cancer treatment in DS, which resulted to reduced costs with savings ranging from 40% to 85%, compared to inpatient surgery (15, 19-22).
In view of these several advantages, we believe that the management of early breast cancer in DS warrants encouragement. Our findings must be interpreted with caution because of the non-randomized design of the study. Moreover, psychological outcomes were evaluated in a relatively small subgroup of early breast cancer patients treated with conserving surgery and SLNB. Therefore, we cannot draw a definitive conclusion. Nonetheless, our findings of improved psychological outlooks for patients treated in DS are intriguing and further studies on a larger scale of patients are warranted.
Footnotes
Authors' Contributions
TS and CC: Conceptualization, data curation, formal analysis, investigation, funding acquisition, writing original draft and editing. FT: Conceptualization, methodology, data curation, formal analysis; GM, IR and NB: Data curation, critical review, editing; JN, EV, and SB: Methodology, formal analysis, investigation.
Conflicts of Interest
All Authors declare that there is no conflict of interest regarding this study.
- Received May 8, 2019.
- Revision received May 22, 2019.
- Accepted May 23, 2019.
- Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved